FibroBiologics (FBLG)

• Market cap: $14.8M
• 1 day: -8.44%
• 5 days: -20.42%
• 1 month: -28.12%
• 3 months: -54.52%
• 6 months: -69.79%
• Year to date: -87.9%
• 1 year: -88.85%
• 5 years: -99.17%
• 10 years: -99.17%
• Sector: Healthcare
• Industry: Biotechnology

About: FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Employees: 13